Shares of MKS Instruments, Inc. (NASDAQ:MKSI) have earned an average rating of “Buy” from the seven research firms that are covering the company, MarketBeat Ratings reports. Six equities research analysts have rated the stock with a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1-year price objective among brokers that have issued a report on the stock in the last year is $122.67.

Several equities research analysts recently commented on MKSI shares. Dougherty & Co boosted their price objective on shares of MKS Instruments from $106.00 to $115.00 and gave the stock a “buy” rating in a research report on Thursday, October 26th. Deutsche Bank boosted their price objective on shares of MKS Instruments from $104.00 to $116.00 and gave the stock a “buy” rating in a research report on Thursday, October 26th. Stifel Nicolaus reiterated a “buy” rating and issued a $108.00 price objective (up from $98.00) on shares of MKS Instruments in a research report on Tuesday, October 24th. BidaskClub lowered shares of MKS Instruments from a “strong-buy” rating to a “buy” rating in a research report on Saturday, December 2nd. Finally, KeyCorp reiterated a “buy” rating on shares of MKS Instruments in a research report on Friday, February 2nd.

MKS Instruments (MKSI) traded up $3.25 during trading on Friday, hitting $103.15. 496,300 shares of the company traded hands, compared to its average volume of 606,510. MKS Instruments has a 1-year low of $64.45 and a 1-year high of $110.60. The company has a quick ratio of 3.06, a current ratio of 4.21 and a debt-to-equity ratio of 0.25. The stock has a market cap of $5,600.00, a price-to-earnings ratio of 16.39, a PEG ratio of 0.99 and a beta of 1.04.

MKS Instruments (NASDAQ:MKSI) last released its quarterly earnings data on Wednesday, January 31st. The scientific and technical instruments company reported $1.71 EPS for the quarter, topping the consensus estimate of $1.63 by $0.08. MKS Instruments had a net margin of 17.70% and a return on equity of 22.51%. The business had revenue of $512.00 million for the quarter, compared to analyst estimates of $500.22 million. During the same period in the previous year, the firm earned $1.05 EPS. The business’s revenue for the quarter was up 26.4% compared to the same quarter last year. research analysts forecast that MKS Instruments will post 7.6 earnings per share for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Friday, March 9th. Shareholders of record on Monday, February 26th will be issued a $0.18 dividend. This represents a $0.72 dividend on an annualized basis and a yield of 0.70%. MKS Instruments’s dividend payout ratio (DPR) is 11.69%.

In other MKS Instruments news, VP Brian Charles Quirk sold 2,000 shares of the company’s stock in a transaction dated Monday, February 5th. The shares were sold at an average price of $105.10, for a total value of $210,200.00. Following the transaction, the vice president now directly owns 11,863 shares in the company, valued at approximately $1,246,801.30. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, CEO Gerard G. Colella sold 10,000 shares of the company’s stock in a transaction dated Friday, January 12th. The shares were sold at an average price of $96.30, for a total transaction of $963,000.00. Following the completion of the transaction, the chief executive officer now owns 5,025 shares in the company, valued at $483,907.50. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 31,139 shares of company stock worth $3,069,492. 1.65% of the stock is owned by insiders.

A number of large investors have recently added to or reduced their stakes in MKSI. Meeder Asset Management Inc. lifted its holdings in MKS Instruments by 311.2% in the 4th quarter. Meeder Asset Management Inc. now owns 1,065 shares of the scientific and technical instruments company’s stock valued at $101,000 after purchasing an additional 806 shares in the last quarter. Krilogy Financial LLC purchased a new position in MKS Instruments in the 3rd quarter valued at about $144,000. Bridgeworth LLC purchased a new position in MKS Instruments in the 3rd quarter valued at about $203,000. Greenwood Capital Associates LLC purchased a new position in MKS Instruments in the 3rd quarter valued at about $204,000. Finally, Advisor Partners LLC purchased a new position in MKS Instruments in the 4th quarter valued at about $206,000. Institutional investors own 95.00% of the company’s stock.

ILLEGAL ACTIVITY WARNING: “MKS Instruments, Inc. (MKSI) Receives $122.67 Consensus Target Price from Analysts” was posted by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are viewing this news story on another domain, it was copied illegally and reposted in violation of US and international copyright legislation. The original version of this news story can be viewed at https://theolympiareport.com/2018/02/13/mks-instruments-inc-mksi-receives-122-67-consensus-target-price-from-analysts.html.

About MKS Instruments

MKS Instruments, Inc is a global provider of instruments, subsystems and process control solutions that measures, controls, powers, delivers, monitors and analyzes critical parameters of advanced manufacturing processes. The Company operates through two segments, including the Vacuum & Analysis segment and the Light & Motion segment.

Receive News & Ratings for MKS Instruments Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MKS Instruments and related companies with MarketBeat.com's FREE daily email newsletter.